SBIR/STTR Research Award

UV emitting nanoparticles as novel radiation sensitizers targeting hypoxic cells

Award identifier 74827fe26e518442b08985101f83f82c1bb218c28b675c9a304de5b8e13548a8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$299,992

Program and phase

STTR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
RADIATION MONITORING DEVICES, INC.
Proposal award date
2017-04-03
Contract end date
2018-08-02
UEI
SCKQA85YU4U4
Solicitation number
PA16-303
Topic code
102

Research abstract

Project Summary Abstract Radiation therapy is one of the primary therapeutic techniques for treating cancer Nearly two thirds of all cancer patients will receive radiation therapy during their illness with an average of radiation treatment episodes Although largely effective radiation therapy like other forms of cancer treatment has difficulty killing hypoxic regions within solid tumors Cellular hypoxia is associated with radiotherapy resistance resulting in the incomplete killing of cancer cells and leading to recurrence and relapse Thus developing techniques to target the hypoxic core of tumors is a major goal of cancer research Nearly of all breast cancers and of locally advanced breast cancers are hypoxic and their altered metabolism is strongly linked to resistance to radiotherapy and systemic therapy In prostate cancer hypoxia is associated with early biochemical relapse after radiotherapy and also with local recurrence in the prostate gland A variety of approaches are being used to enhance the efficacy of radiation therapy and reduce dose These include the use of nanoparticles to enhance the radiosensitization of tumor tissue reversing radiation resistance in tumor tissue and increasing the radioresistance of healthy tissue In this proposed effort we will develop a new technique that enhances radiation treatment by using a sensitizer that both increases the energy deposited locally within the tumor and generates UV photons in the vicinity of the DNA in cancer cells Our sensitizer consists of scintillating nanoparticles that emit UV radiation capable of both directly damaging the DNA in hypoxic cancer cells In addition these particles will be composed of high atomic number elements with much higher radiation stopping power than the low atomic number elements that make up tissue This will enhance the efficacy of the high energy X rays used in radiation treatment by down converting the X ray photon energy into lower energy X rays and particles which have a much higher energy deposition rate linear energy transfer LET We have performed a preliminary experiment which gave encouraging results showing an increase in cell death using the LuPO scintillating nanoparticles In Phase I of this effort we will model photon transport and energy conversion for both X rays and UV photons and experimentally demonstrate the effectiveness of the concept in vitro In Phase II we will develop size homogenous nanoparticles suitable for use in exhaustive in vitro cell experiments and preclinical studies Project Narrative This project will investigate enhancing the efficacy of radiation treatment of cancer by using scintillating nanoparticle sensitizers that emit UV photons This sensitizer will enhance the treatment in two ways first by generating UV photons in the immediate vicinity of cancer cells which can interact directly with its DNA to cause lethal damage in an oxygen independent way and second by making more efficient use of the X ray energy that strikes the tumor cell by generating softer more tissue absorbent x rays and photoelectrons The end result will be UV generating nanoparticles with a higher efficacy in the treatment of resistant hypoxic cells of the tumor filling an important unmet clinical need

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

930 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $346,950,619. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Energy, Department of Health and Human Services, Department of Defense, National Aeronautics and Space Administration, National Science Foundation, Department of Homeland Security

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.